European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols.
Damian Swieczkowski, Aleksander Kwaśny, Krzysztof Sadko, Wiesław Jerzy Cubała
Published: 202610.1016/j.euroneuro.2025.112746
Abstract
Psilocybin-assisted therapies are increasingly studied for Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD), and methodological rigor requires both pharmacological evaluation and consistent reporting of non-pharmacological var…
Preview only. Read the full abstract at the source